Nu există produse adăugate.
Bovine Folic Acid / Vitamin B9 ELISA Kit (A75081-96)
Cod: A75081-96
Bovine Folic Acid / Vitamin B9 ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of bovine Folic Acid / Vitamin B9 in serum, plasma, tissue homogenates, and other biological fluids.
Numar teste:
96T
3.774,68 Lei
Timp de livrare: 2-3 saptamani
Preturile includ TVA 19%
Bovine Folic Acid / Vitamin B9 ELISA Kit (A75081) employs the competitive enzyme immunoassay technique for the quantitative measurement of bovine Folic Acid / Vitamin B9 in serum, plasma, tissue homogenates, and other biological fluids. The 96-well microtiter plate has been pre-coated with Folic Acid / Vitamin B9 antigen. During the incubation, Folic Acid / Vitamin B9 present in the samples or standards competes with the fixed amount of immobilized Folic Acid / Vitamin B9 for binding sites on the Biotinylated Anti-Folic Acid / Vitamin B9 Antibody. The more Folic Acid / Vitamin B9 present in a sample or standard, the less Biotinylated Anti-Folic Acid / Vitamin B9 Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-Folic Acid / Vitamin B9 Antibody is removed by washing, and an HRP-Streptavidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of Folic Acid / Vitamin B9 present in each sample or standard. The concentration of Folic Acid / Vitamin B9 can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.
- Serum, plasma, tissue homogenates, and other biological fluids.
- ANTIBODIES
- Competitive (quantitative)
- 78.125-5000 pg/ml
- 46.875 pg/ml
Trebuie să fiţi autentificat pentru a putea adaugă comentarii.